Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children

被引:0
|
作者
Barbara Jarząb
Daria Handkiewicz Junak
Jan Włoch
Barbara Kalemba
Józef Roskosz
Aleksandra Kukulska
Zbigniew Puch
机构
[1] Department of Nuclear Medicine and Endocrine Oncology,
[2] Centre of Oncology,undefined
[3] Maria Skłodowska – Curie Memorial Institute,undefined
[4] Gliwice,undefined
[5] Poland,undefined
[6] Department of Surgery,undefined
[7] Centre of Oncology,undefined
[8] Maria Skłodowska – Curie Memorial Institute,undefined
[9] Gliwice,undefined
[10] Poland,undefined
来源
European Journal of Nuclear Medicine | 2000年 / 27卷
关键词
Key words: Thyroid cancer; Children; Extent of surgery; Radioiodine treatment;
D O I
暂无
中图分类号
学科分类号
摘要
At most centres, the standard treatment for differentiated thyroid cancer (DTC) comprises total thyroidectomy, radioiodine treatment and thyroid-stimulating hormone (TSH) suppressive therapy. There is, however, considerable disagreement over the appropriate treatment for DTC in children. Some dispute the use of total thyroidectomy and/or question the routine application of iodine-131 therapy in children. The aim of this study was to perform a retrospective analysis of treatment results and prognostic factors for DTC in children treated at our centre. The study included 109 children with DTC (aged 6–17 years). The primary treatment comprised total thyroidectomy in 81 cases, radioiodine therapy in 85 cases and TSH suppressive therapy with l-thyroxine in all patients. Uni- and multivariate analysis of prognostic factors for disease-free survival was performed using the Cox regression method. The actuarial survival rate was 100%, and the 5- and 10-year actuarial disease-free survival rates were 80% and 61% respectively. Univariate analysis revealed that older age, total thyroidectomy and radioiodine treatment had a positive impact on disease-free survival whereas there were no statistical differences with regard to the child’s sex, histological type of cancer or lymph node status. On multivariate analysis, radical surgery was estimated to be the most significant factor (P=0.007) for disease-free survival, while less than total thyroidectomy increased the relative risk of relapse by a factor of 10. Radioiodine treatment decreased the relative risk of relapse by a factor of 5, but with borderline significance (P=0.07). Permanent postoperative complications were observed in 17% of children: in 11 laryngeal palsy occurred, in six there was hypoparathyroidism, and one suffered from both. It is concluded that total thyroidectomy and radioiodine treatment significantly improve recurrence-free survival in children and should be routinely applied even in young children as the primary treatment of DTC.
引用
收藏
页码:833 / 841
页数:8
相关论文
共 50 条
  • [31] Treatment outcomes in pediatric differentiated thyroid carcinoma
    Bhavani, Nisha
    Bhadran, Kingini
    Nair, Vasantha
    Menon, Usha V.
    Pavithran, Praveen V.
    Menon, Arun S.
    Abraham, Nithya
    Pankaj, Aswin
    Kumar, Harish
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 31 (10) : 1117 - 1122
  • [32] INTRACRANIAL EPENDYMOMA IN CHILDREN - ANALYSIS OF PROGNOSTIC FACTORS
    CHIU, JK
    WOO, SY
    ATER, J
    CONNELLY, J
    BRUNER, JM
    MAOR, MH
    VANEYS, J
    OSWALD, MJ
    SHALLENBERGER, R
    JOURNAL OF NEURO-ONCOLOGY, 1992, 13 (03) : 283 - 290
  • [33] Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years
    Ito, Yasuhiro
    Kihara, Minoru
    Takamura, Yuuki
    Kobayashi, Kaoru
    Miya, Akihiro
    Hirokawa, Mitsuyoshi
    Miyauchi, Akira
    ENDOCRINE JOURNAL, 2012, 59 (07) : 539 - 545
  • [34] Tumor size is an independent negative prognostic factor for event free survival in children with differentiated thyroid cancer
    Parvathareddy, Sandeep Kumar
    Siraj, Abdul K. K.
    Annaiyappanaidu, Padmanaban
    Siraj, Nabil
    Haqawi, Wael
    Al-Sobhi, Saif S. S.
    Al-Dayel, Fouad
    Al-Kuraya, Khawla S. S.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [35] PROGNOSTIC FACTORS IN METASTATIC NEUROBLASTOMA - A MULTIVARIATE-ANALYSIS OF 182 CASES
    BERTHOLD, F
    TRECHOW, R
    UTSCH, S
    ZIESCHANG, J
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1992, 14 (03): : 207 - 215
  • [36] Differentiated thyroid cancer in children: diagnosis and management
    Dinauer, Catherine A.
    Breuer, Christopher
    Rivkees, Scott A.
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (01) : 59 - 65
  • [37] Differentiated Thyroid Cancer in Children and Adolescents: Long Term Outcome and Risk Factors for Persistent Disease
    Sapuppo, Giulia
    Hartl, Dana
    Fresneau, Brice
    Hadoux, Julien
    Breuskin, Ingrid
    Baudin, Eric
    Rigaud, Charlotte
    Guerlain, Joanne
    Al Ghuzlan, Abir
    Leboulleux, Sophie
    Schlumberger, Martin
    Lamartina, Livia
    CANCERS, 2021, 13 (15)
  • [38] Risk factors for baclofen pump infection in children: a multivariate analysis
    Spader, Heather S.
    Bollo, Robert J.
    Bowers, Christian A.
    Riva-Cambrin, Jay
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2016, 17 (06) : 756 - 762
  • [39] Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System
    Pires, Barbara Pereira
    Garcia Alves, Paulo Alonso, Jr.
    Bordallo, Maria Alice
    Bulzico, Daniel Alves
    Proenca Lobo Lopes, Flavia Paiva
    Farias, Terence
    Dias, Fernando
    Lima, Roberto Araujo
    Santos Gisler, Izabella Costa
    Coeli, Claudia Medina
    Carvalhaes de Oliveira, Raquel Vasconcellos
    Corbo, Rossana
    Vaisman, Mario
    Vaisman, Fernanda
    THYROID, 2016, 26 (10) : 1480 - 1487
  • [40] Differentiated thyroid carcinoma: comparison of histopathologic characteristics, clinical course, and outcome between young children and adolescents
    Motazedian, M.
    Shafiei, B.
    Vatankhah, P.
    Hoseinzadeh, S.
    Mirzababaee, M.
    Fathollahi, L.
    Ansari, M.
    Baharfar, N.
    Tabeie, F.
    Asli, I. Neshandar
    MEDICAL ONCOLOGY, 2013, 30 (02)